Login / Signup

Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals.

A Karim EmbongPhuong Nguyen-ContantJiong WangPreshetha KanagaiahFrancisco A ChavesTheresa F FitzgeraldQian ZhouGabrielle KosoyAngela R BrancheBenjamin L MillerMartin S ZandMark Y SangsterDavid J Topham
Published in: Pathogens (Basel, Switzerland) (2022)
Infection with the β-coronavirus SARS-CoV-2 typically generates strong virus-specific antibody production. Antibody responses against novel features of SARS-CoV-2 proteins require naïve B cell activation, but there is a growing appreciation that conserved regions are recognized by pre-existing memory B cells (MBCs) generated by endemic coronaviruses. The current study investigated the role of pre-existing cross-reactive coronavirus memory in the antibody response to the viral spike (S) and nucleocapsid (N) proteins following SARS-CoV-2 infection. The breadth of reactivity of circulating antibodies, plasmablasts, and MBCs was analyzed. Acutely infected subjects generated strong IgG responses to the S protein, including the novel receptor binding domain, the conserved S2 region, and to the N protein. The response included reactivity to the S of endemic β-coronaviruses and, interestingly, to the N of an endemic α-coronavirus. Both mild and severe infection expanded IgG MBC populations reactive to the S of SARS-CoV-2 and endemic β-coronaviruses. Avidity of S-reactive IgG antibodies and MBCs increased after infection. Overall, findings indicate that the response to the S and N of SARS-CoV-2 involves pre-existing MBC activation and adaptation to novel features of the proteins, along with the potential of imprinting to shape the response to SARS-CoV-2 infection.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • working memory
  • binding protein
  • transcription factor
  • amino acid
  • protein protein
  • small molecule
  • high resolution
  • atomic force microscopy
  • disease virus
  • drug induced